Goodwin Procter and Wilson Sonsini Goodrich & Rosati represented MBX Biosciences, Inc. in the offering, and Davis Polk & Wardwell represented the underwriters. MBX Biosciences, Inc....
MBX Biosciences’ $187.7 Million IPO
Sonic Healthcare’s $150 Million Acquisition of Pathology Watch
Goodwin advised Pathology Watch on the sale to Sonic Healthcare. Sonic Healthcare acquired Utah-based medical-tech provider Pathology Watch for US$150 million in what the Australian company...
York Capital Management’s Partnership with Comprehensive Rehab Consultants
Goodwin Procter advised York Capital Management in its strategic growth investment in Comprehensive Rehab Consultants. William Blair acted as the sell-side investment banking advisor to CRC....
Onex’s Investment in Unanet
Goodwin Procter advised Unanet and JMI Equity on the deal, while Latham & Watkins represented Onex. Unanet announced a new round of strategic financing from Onex Corporation...
Glass Houses’ $200 Million Initial Public Offering
Kirkland & Ellis counseled Glass Houses Acquisition Corp. on the offering. Glass Houses Acquisition Corp., a blank check company formed for the purpose of effecting a...